Ticker >

Lincoln Pharma share price

Lincoln Pharmaceuticals Ltd.

NSE: LINCOLN BSE: 531633 SECTOR: Pharmaceuticals & Drugs  53k   304   41

575.50
-1.40 (-0.24%)
BSE: 17 May 04:01 PM

Price Summary

Today's High

₹ 584.75

Today's Low

₹ 566.8

52 Week High

₹ 754.25

52 Week Low

₹ 365.4

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1152.71 Cr.

Enterprise Value

1120.86 Cr.

No. of Shares

2 Cr.

P/E

12.35

P/B

1.94

Face Value

₹ 10

Div. Yield

0.31 %

Book Value (TTM)

₹  295.98

CASH

33.85 Cr.

DEBT

2 Cr.

Promoter Holding

49.53 %

EPS (TTM)

₹  46.58

Sales Growth

8.1%

ROE

15.59 %

ROCE

21.82%

Profit Growth

5.11 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.1%
3 Year10.71%
5 Year9.45%

Profit Growth

1 Year5.11%
3 Year13.72%
5 Year17.35%

ROE%

1 Year15.59%
3 Year17.17%
5 Year17.67%

ROCE %

1 Year21.82%
3 Year23.77%
5 Year22.96%

Debt/Equity

0.004

Price to Cash Flow

29.44

Interest Cover Ratio

50.512198728375

CFO/PAT (5 Yr. Avg.)

1.01927403934088

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 49.53 0
Dec 2023 49.8 0
Sep 2023 50.53 0
Jun 2023 48.67 0
Mar 2023 47 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 23.7729531257243% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 50.512198728375.
  • The company has an efficient Cash Conversion Cycle of 10.1805678814143 days.
  • Company has a healthy liquidity position with current ratio of 4.07206593385986.
  • The company has a good cash flow management; CFO/PAT stands at 1.01927403934088.

 Limitations

  • The company has shown a poor revenue growth of 10.7084158569204% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 112.46 135.62 155.99 146.45 142.49
Total Expenditure 95.86 114.9 124.84 116.79 124.11
Operating Profit 16.6 20.72 31.15 29.66 18.38
Other Income 3.95 7.69 8.7 11.02 7.02
Interest 1.15 0.42 0.39 0.16 0.5
Depreciation 2.41 2.55 2.58 2.81 2.69
Exceptional Items 0 0 0 0 0
Profit Before Tax 16.98 25.45 36.87 37.71 22.22
Tax 4.42 6.43 9.21 9.67 3.62
Profit After Tax 12.56 19.01 27.65 28.04 18.6
Adjusted EPS (Rs) 6.27 9.49 13.81 14 9.28

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 353.04 376.09 422.91 472.08 510.31
Total Expenditure 292.71 316.72 335.87 376.61 421.14
Operating Profit 60.33 59.37 87.04 95.47 89.17
Other Income 6.58 12.13 5.74 10 22.48
Interest 3.84 1.98 1.55 1.45 2.03
Depreciation 4.92 5.47 7.56 8.09 9.17
Exceptional Items 0 0 0 0 0
Profit Before Tax 58.14 64.05 83.67 95.93 100.46
Tax 11.51 14.48 21.42 26.57 27.56
Net Profit 46.64 49.56 62.25 69.35 72.9
Adjusted EPS (Rs.) 23.32 24.78 31.08 34.63 36.4

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 20 20 20.03 20.03 20.03
Total Reserves 242.6 284.49 346.36 412.85 482.44
Borrowings 1.69 0.52 0.14 0 0
Other N/C liabilities 23.22 37.47 40.73 41.74 37.88
Current liabilities 90.02 69.44 93.45 110.46 95.99
Total Liabilities 377.54 411.92 500.72 585.08 636.34
Assets
Net Block 88.45 91.03 110.64 131.88 150.53
Capital WIP 1.94 0.04 1.69 16.05 6.71
Intangible WIP 0 0 0 0 0
Investments 27.74 25.79 0.05 0.05 0.05
Loans & Advances 50.27 65.69 61.57 62.57 87.71
Other N/C Assets 0.33 0.03 0.45 1.75 0.47
Current Assets 208.81 229.35 326.31 372.78 390.87
Total Assets 377.54 411.92 500.72 585.08 636.34
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 58.14 64.05 83.67 95.93 100.46
Adjustment 6.53 5.38 4.75 1.49 -0.29
Changes in Assets & Liabilities 3.01 15.27 0.42 2.4 -31.4
Tax Paid -16.63 -13.98 -19.45 -23.64 -29.61
Operating Cash Flow 51.06 70.71 69.39 76.18 39.16
Investing Cash Flow -22.32 -28.99 -64.39 -78.08 -36.64
Financing Cash Flow -29.88 -38.1 -5.74 -2.56 -4.5
Net Cash Flow -1.14 3.61 -0.74 -4.46 -1.99

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 47.00 48.67 50.53 49.80 49.53
aashish rajanibhai patel 7.51 8.29 10.60 10.60 10.60
anand arvinbhai patel 1.41 1.41 1.41 1.41 1.66
arvindbhai gulabdas patel... 0.55 0.55 0.55 0.55 0.55
bhagirathbhai tribhovanda... 0.12 0.12 0.12 0.12 0.12
dharmistaben hasmukhbhai ... 0.32 0.32 0.32 0.32 0.32
dharmisthaben bhagirath p... 0.62 0.62 0.62 0.62 0.62
downtown finance pvt. ltd... 0.53 0.53 0.53 0.53 0.53
downtown travels llp 2.37 2.37 2.37 2.37 2.37
hansaben arvindbhai patel... 0.88 0.88 0.88 0.88 0.88
hashmukhbhai ishwarlal pa... 1.87 1.87 1.87 1.87 1.87
jigar hasmukhbhai patel 0.43 0.43 0.43 0.43 0.43
kailashben mahendrabhai p... 2.40 2.40 2.40 2.40 2.40
mahendrabhai gulabdas pat... 3.37 3.37 3.37 3.37 3.37
mansi munjal patel 1.00 1.00 1.00 1.00 1.00
mihir viththalbhai patel 0.41 0.41 0.41 0.41 0.41
munjal mahendrabhai patel... 11.23 12.13 13.13 13.13 13.13
nidhi mahendrabhai patel 0.27 0.27 0.27 0.27 0.27
patel aniruddh h 0.43 0.43 0.43 0.43 0.43
patel nishitkumar maheshb... 0.91 0.91 0.91 0.91 0.77
rajanikant gulabdas patel... 3.78 3.78 3.78 3.78 3.78
renukaben maheshbhai pate... 0.87 0.87 0.87 0.87 0.49
shivani b. shah 1.03 1.03 1.03 1.03 1.03
sunmed corporation llp 2.50 2.50 2.50 2.50 2.50
manguben ishwarlal patel 0.72 0.72 0.72 - -
kalpanaben rajanikant pat... 1.46 1.46 - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 53.00 51.33 49.47 50.20 50.47
dheeraj kumar lohia 1.32 1.32 1.32 1.32 1.32
investor education and pr... 0.21 0.21 0.21 - 0.26
kamlesh jayantilal patel 1.13 1.25 1.03 - 1.09
kishor m. shah 2.39 2.39 2.39 2.39 2.39
llp 0.06 0.08 0.07 0.08 0.11
parikh mitesh jagdishbhai... 1.01 1.01 1.01 1.01 1.01
rimo capital fund lp - - 1.25 1.44 1.25
investor education and pr... - - - 0.26 -
digital biotech pvt. ltd.... 4.29 2.11 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ3FY21 24 May 2021
  • PresentationQ2FY21 23 Dec 2020
  • PresentationQ1FY21 23 Dec 2020
  • Presentation Q3FY20 19 May 2020

Company News

Lincoln Pharmaceuticals informs about outcome of board meeting16 May 2024, 3:13PM Lincoln Pharma - Quaterly Results16 May 2024, 12:14PM Lincoln Pharma - Quaterly Results16 May 2024, 12:14PM Lincoln Pharma - Quaterly Results16 May 2024, 12:14PM Lincoln Pharmaceuticals informs about newspaper publication15 May 2024, 5:53PM Lincoln Pharmaceuticals informs about disclosure29 Feb 2024, 11:02AM Lincoln Pharmaceuticals informs about disclosure 29 Feb 2024, 11:01AM Lincoln Pharmaceuticals informs about disclosure26 Feb 2024, 2:22PM Lincoln Pharmaceuticals informs about disclosure23 Feb 2024, 12:28PM Lincoln Pharmaceuticals informs about resignation of director22 Feb 2024, 5:09PM Lincoln Pharma - Quaterly Results8 Feb 2024, 12:28PM Lincoln Pharma - Quaterly Results8 Feb 2024, 12:28PM Lincoln Pharma - Quaterly Results8 Feb 2024, 12:28PM Lincoln Pharmaceuticals informs about compliances-certificate8 Jan 2024, 4:34PM Lincoln Pharmaceuticals informs about newspaper advertisement3 Nov 2023, 12:53PM Lincoln Pharmaceuticals informs about outcome of board meeting2 Nov 2023, 2:47PM Lincoln Pharmaceuticals informs about outcome of board meeting2 Nov 2023, 2:34PM Lincoln Pharma - Quaterly Results2 Nov 2023, 12:24PM Lincoln Pharma - Quaterly Results2 Nov 2023, 12:24PM Lincoln Pharma - Quaterly Results2 Nov 2023, 12:24PM Lincoln Pharmaceuticals informs about newspaper advertisement26 Aug 2023, 2:59PM Lincoln Pharmaceuticals informs about press release11 Aug 2023, 12:18PM Lincoln Pharma - Quaterly Results10 Aug 2023, 12:22PM Lincoln Pharma - Quaterly Results10 Aug 2023, 12:22PM Lincoln Pharma - Quaterly Results10 Aug 2023, 12:22PM Lincoln Pharmaceuticals informs about press release26 May 2023, 1:13PM Lincoln Pharmaceuticals informs about outcome of board meeting25 May 2023, 3:09PM Lincoln Pharma - Quaterly Results25 May 2023, 11:42AM Lincoln Pharma - Quaterly Results25 May 2023, 11:42AM Lincoln Pharma - Quaterly Results25 May 2023, 11:42AM Lincoln Pharmaceuticals informs about issuance of duplicate share certificate12 May 2023, 4:55PM Lincoln Pharmaceuticals informs about revised disclosures 4 May 2023, 12:59PM Lincoln Pharma - Quaterly Results9 Feb 2023, 12:51PM Lincoln Pharma - Quaterly Results9 Feb 2023, 12:51PM Lincoln Pharma - Quaterly Results9 Feb 2023, 12:51PM Lincoln Pharmaceuticals informs about disclosure 16 Dec 2022, 4:00PM Lincoln Pharmaceuticals informs about disclosure 7 Dec 2022, 4:38PM Lincoln Pharmaceuticals informs about disclosure 3 Dec 2022, 3:34PM Lincoln Pharmaceuticals informs about disclosure 30 Nov 2022, 5:09PM Lincoln Pharmaceuticals informs about disclosure of related party transactions24 Nov 2022, 5:07PM Lincoln Pharmaceuticals informs about outcome of board meeting 10 Nov 2022, 5:10PM Lincoln Pharma - Quaterly Results10 Nov 2022, 11:28AM Lincoln Pharma - Quaterly Results10 Nov 2022, 11:28AM Lincoln Pharmaceuticals informs about outcome of board meeting9 Aug 2022, 3:01PM Lincoln Pharma - Quaterly Results9 Aug 2022, 1:29PM Lincoln Pharma - Quaterly Results9 Aug 2022, 1:29PM Lincoln Pharma - Quaterly Results9 Aug 2022, 1:29PM Lincoln Pharmaceuticals informs about disclosure7 Jun 2022, 4:55PM Lincoln Pharmaceuticals informs about audited financial results19 May 2022, 3:05PM Lincoln Pharma - Quaterly Results19 May 2022, 1:10PM

Lincoln Pharma Stock Price Analysis and Quick Research Report. Is Lincoln Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Lincoln Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Lincoln Pharma cash from the operating activity was Rs 39.1562 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Lincoln Pharma has a Debt to Equity ratio of 0.004 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Lincoln Pharma , the EPS growth was 5.11089932420724 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Lincoln Pharma has OPM of 17.4731064798412 % which is a good sign for profitability.
     
  • ROE: Lincoln Pharma have a average ROE of 15.5875912771634 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Lincoln Pharma is Rs 577.65. One can use valuation calculators of ticker to know if Lincoln Pharma share price is undervalued or overvalued.
Last Updated on:
Brief about Lincoln Pharma

Lincoln Pharmaceuticals Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Lincoln Pharmaceuticals Limited is a prominent player in the pharmaceutical industry of India. Established in [year], the company has carved a niche for itself by delivering high-quality medicinal products and establishing a strong presence in both domestic and international markets. With a relentless focus on research and development, Lincoln Pharmaceuticals Limited is committed to providing affordable healthcare solutions to its customers.

Lincoln Pharmaceuticals Limited - Share Price

The share price of Lincoln Pharmaceuticals Limited reflects its market valuation and investor sentiment. It is an essential factor to consider for long-term stock investors looking for stock analysis. By analyzing the historical share price movement, investors can gain insights into the performance of the company and make informed investment decisions. Lincoln Pharmaceuticals Limited's share price information can be accessed on our website, along with pre-built screening tools that can assist in understanding the stock dynamics.

Lincoln Pharmaceuticals Limited - Balance Sheet

Analyzing the balance sheet of Lincoln Pharmaceuticals Limited provides a comprehensive understanding of the company's financial health and stability. A strong balance sheet demonstrates the company's ability to meet its short-term and long-term obligations and reflects its overall performance. Our website offers downloadable annual reports where investors can find detailed information about Lincoln Pharmaceuticals Limited's balance sheet. Additionally, our premium features of fair value calculation tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis enable investors to evaluate the inherent value of the stock.

Lincoln Pharmaceuticals Limited - Annual Report

The annual report of Lincoln Pharmaceuticals Limited serves as a valuable source of information for investors. It provides insights into the company's financial performance, business strategies, and future plans. As a long-term stock investor, it is crucial to study the annual report to gain a deeper understanding of the company's operations, competitive position, and growth prospects. At our website, investors can access the downloadable annual reports of Lincoln Pharmaceuticals Limited, facilitating comprehensive stock analysis.

Lincoln Pharmaceuticals Limited - Dividend

Dividends play a significant role in generating income for stock investors. Lincoln Pharmaceuticals Limited has a track record of regularly rewarding its shareholders through dividend payments. Analyzing the dividend history and payout ratio of the company is essential for investors seeking sustainable returns on their investments. Our website offers data on Lincoln Pharmaceuticals Limited's dividend payments, enabling investors to evaluate the stock's income potential.

Lincoln Pharmaceuticals Limited - Quarterly Result

Quarterly results reflect the financial performance of Lincoln Pharmaceuticals Limited for a specific period. As a long-term stock investor, it is crucial to assess the company's quarterly results to gain insights into its revenue growth, profitability, and overall financial stability. Our website provides access to Lincoln Pharmaceuticals Limited's quarterly result data, allowing investors to track the company's progress and make informed investment decisions. Additionally, our fair value calculation tools aid in comprehending the stock's intrinsic value.

Lincoln Pharmaceuticals Limited - Stock Price

The stock price of Lincoln Pharmaceuticals Limited is influenced by various factors such as market trends, company performance, and investor sentiment. Analyzing stock price movements can assist long-term investors in understanding the market's perception of the company's prospects. Our website provides a price chart that displays the historical stock price of Lincoln Pharmaceuticals Limited, helping investors assess the stock's volatility and trends over time.

Lincoln Pharmaceuticals Limited - News

Keeping abreast of the latest news and developments related to Lincoln Pharmaceuticals Limited is crucial for investors. News articles provide insights into the company's operations, new product launches, collaborations, regulatory updates, and other significant events that may impact the stock's performance. Our website offers a comprehensive collection of news articles related to Lincoln Pharmaceuticals Limited, allowing investors to stay informed and make well-informed investment decisions.

Lincoln Pharmaceuticals Limited - Concall Transcripts

Concall transcripts provide a detailed record of the discussions that take place during the company's conference calls with analysts and investors. These transcripts offer valuable insights into the company's management, business strategies, and outlook for the future. Lincoln Pharmaceuticals Limited's concall transcripts are available for download on our website, providing investors with access to essential information for stock analysis and decision-making.

Lincoln Pharmaceuticals Limited - Investor Presentations

Investor presentations serve as a medium for companies to present their strategy and performance to the investment community. Lincoln Pharmaceuticals Limited's investor presentations are a valuable resource for long-term investors seeking detailed information about the company's operations, competitive positioning, growth prospects, and future plans. The downloadable investor presentations available on our website enable investors to gain a comprehensive understanding of Lincoln Pharmaceuticals Limited and make informed investment decisions.

Lincoln Pharmaceuticals Limited - Promoters

Promoters play a crucial role in the success and development of a company. They are responsible for its establishment, growth, and strategic decisions. In the case of Lincoln Pharmaceuticals Limited, the promoters have shown exemplary leadership and have been instrumental in driving the company's growth. Analyzing the background and contributions of the promoters provides valuable insights into the company's stability and long-term prospects.

Lincoln Pharmaceuticals Limited - Shareholders

Lincoln Pharmaceuticals Limited's shareholders form a critical part of the company's ownership structure. A diverse and well-distributed shareholder base indicates a healthy investor interest and confidence in the stock. Understanding the composition of the shareholder base and the involvement of institutional investors provides insights into the market's perception of the stock and its growth potential.

In conclusion, Lincoln Pharmaceuticals Limited offers a comprehensive platform for long-term stock investors seeking detailed stock analysis. Our website provides access to essential information such as company profile, share price, balance sheet, annual reports, dividends, quarterly results, stock price, news, concall transcripts, investor presentations, promoters, and shareholders. With our pre-built screening tools and premium features for fair value calculations, investors can make well-informed decisions and maximize their investment potential.

Read More
X